SRTS
Sensus Healthcar (SRTS)
NASDAQ
$2.84$0.00 (0.00%)
Price as of Jun 03, 2026 7:14 PM EDT
  • $50.9M
    Market Cap
  • -41.20%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 12
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders

Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.

10/09/2025, 1:00 PM • GlobeNewswire

SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders

Law firm investigating potential securities law violations by Sensus Healthcare after company reported significant revenue decline and stock price drop in Q2 2025.

10/09/2025, 12:58 PM • GlobeNewswire

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Bragar Eagel & Squire is investigating potential claims against AVITA Medical after the company reported a six-month backlog in unpaid provider claims for Recell procedures, which caused a 21% stock price decline.

10/09/2025, 12:49 PM • GlobeNewswire

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

Sensus Healthcare reported Q2 2025 financial results with decreased revenue and missed earnings estimates, leading to a 35.32% stock price drop.

08/31/2025, 8:13 AM • GlobeNewswire

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sensus Healthcare reported Q2 2025 financial results with lower revenue and earnings, leading to a significant stock price decline and potential securities fraud investigation by Portnoy Law Firm.

08/28/2025, 3:43 PM • GlobeNewswire

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sensus Healthcare reported Q2 2025 financial results with a revenue decline of 20.7% and missed analyst earnings estimates, leading to a 35.3% stock price drop.

08/21/2025, 5:40 PM • GlobeNewswire

Peers

Statistics

More
Day Range
$2.78
$3.01
$2.84
1-Year Range
$2.84
$5.65
$2.84
Latest Close$2.84
Change
-$0.01 (-0.35%)
Volume80,255
Market Cap$50.9M
Shares Outstanding16.5M
P/E (TTM)-25.54
Diluted EPS (TTM)-$0.12
Enterprise Value$32.5M

Information as of 06/02/2026

Company Profile

SENSUS HEALTHCARE INC
SENSUS HEALTHCARE INC
https://sensushealthcare.com
$50.9M
Market Cap
-$2.0M
Net Income
Sector: Healthcare
Industry: Medical Devices
851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487
561 922 5808

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Key Executives

  • Joseph C. Sardano
  • Michael J. Sardano
  • Javier Rampolla
  • Carlton Chow
  • Magdalena Martinez

Current Ownership Distribution

  • Institutions72.4M (69.93%)
  • Mutual Funds26.3M (25.37%)
  • Insiders4.9M (4.69%)
  • Other0 (0.00%)